Humacyte

About:

Humacyte develops products for vascular diseases and replacement of anatomical conduits.

Website: http://humacyte.com

Twitter/X: humacyte

Top Investors: Alexandria Venture Investments, OrbiMed, Fresenius Medical Care, Silicon Valley Bank, Access Industries

Description:

Humacyte develops products for vascular disease and replacement of anatomical conduits. It offers human tissue-based products for regenerative medicine and vascular surgery applications; off-the-shelf extracellular matrix tissue products, which are formed in vitro from banked vascular smooth muscle cells and then decellularized to eliminate the risk of rejection; and vascular grafts.

Total Funding Amount:

$748M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Morrisville, North Carolina, United States

Founded Date:

2004-01-01

Founders:

Juliana L. Blum, Laura E. Niklason

Number of Employees:

101-250

Last Funding Date:

2024-11-14

IPO Status:

Public

© 2025 bioDAO.ai